Histopathological Changes in Mycosis Fungoides
Evaluation of Histopathological Changes in the Non-lesional Skin of Stage 1A Mycosis Fungoides Patients
1 other identifier
interventional
10
1 country
1
Brief Summary
Patients with mycosis fungoides stage 1A disease have patch and plaque lesions less than %10 of body skin area. Aim of the study is to compare lesional and non-lesional skin of mycosis fungoides patients, and to decide if the systemic treatment is better or local treatment is better for them. Two biopsies for each patient were taken from lesional and non-lesional skin area.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2023
CompletedFirst Submitted
Initial submission to the registry
June 6, 2023
CompletedFirst Posted
Study publicly available on registry
June 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2024
CompletedFebruary 13, 2024
February 1, 2024
1.5 years
June 6, 2023
February 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CD4+ T cells in epidermis
Histopathologically clonal T lymphocytes in epidermis reveal the diagnosis. If they are seen in non-lesional skin, then lesional specific local treatment is not enough for the disease.
6 months
Study Arms (2)
lesional skin
EXPERIMENTALlesional skin of mycosis fungoides stage 1A patients
non-lesional skin
EXPERIMENTALnon-lesional skin of mycosis fungoides stage 1A patients
Interventions
Eligibility Criteria
You may qualify if:
- Histopathologically confirmed mycosis fungoides stage 1A patients
You may not qualify if:
- Mycosis fungoides patients with other stages
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bezmialem Vakif University Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2023
First Posted
June 15, 2023
Study Start
May 1, 2023
Primary Completion
October 31, 2024
Study Completion
October 31, 2024
Last Updated
February 13, 2024
Record last verified: 2024-02